Drug makers to grapple with worst performance

Local drug manufacturers are seeking ways to boost their sluggish sales in overseas markets abroad as their profits continue to fall in the domestic market after comprehensive price cuts of drugs by the government in April.

Korean drug companies are trying to survive the government’s price cuts by slashing production costs and collaborating with foreign companies to sell products. But those ...